Erythropoietin as a possible mechanism for the effects of intermittent hypoxia on bodyweight, serum glucose and leptin in mice

Regulatory Peptides
Ling QinSusan T Howard

Abstract

The aim of this study was to determine the effects of intermittent hypoxia training (IHT), with and without fatty-diet, on bodyweight, serum glucose, leptin, insulin, and their receptors, and to test whether erythropoietin (EPO) mediates these effects. Kunming mice were divided into four groups. 1: untreated control; 2: IHT; 3: fatty-diet; 4: fatty-diet and IHT. After 40 days exposure to IHT, the bodyweight, serum glucose, serum leptin, insulin and EPO were measured by ELISA. Liver leptin and insulin receptors were quantified. A separate set of mice were treated with several doses of EPO (0-320 U/kg i.p.) for 5 days. In addition, human hepatic cell lines were treated with EPO for 24h and the expression of genes OB-Ra, OB-Rb and IR were measured using RT-PCR. IHT reduced bodyweight and serum glucose, with corresponding increases in the serum levels of leptin, insulin, EPO and expression of leptin and insulin receptors in liver. Repeated EPO treatment increased serum leptin concentration, but had no effects on insulin levels. The expression of the genes OB-Ra, OB-Rb and IR were increased after EPO treatment. We postulate that, in mice, IHT reduces bodyweight and serum glucose by increasing EPO synthesis which secondarily increase...Continue Reading

References

Jan 11, 1996·Nature·J Scott
Mar 1, 1996·Current Opinion in Hematology·G L Wang, G L Semenza
May 18, 2001·Biochemical Society Transactions·K LinnemannC Fusch
Dec 12, 2001·Endocrine Reviews·J NakaeD Accili
Mar 27, 2004·American Journal of Respiratory and Critical Care Medicine·Kerstin M OltmannsAchim Peters
Apr 15, 2004·European Journal of Applied Physiology·Marco ZaccariaMaurizio Varnier
Oct 22, 2005·Exercise and Sport Sciences Reviews·David J Dyck
May 10, 2008·Journal of Neurochemistry·Armando P SignoreJun Chen
Feb 6, 2010·Obesity·Florian J LipplRainald Fischer

❮ Previous
Next ❯

Citations

Apr 5, 2013·Obesity Reviews : an Official Journal of the International Association for the Study of Obesity·B Kayser, S Verges
May 23, 2013·Acta Physiologica·A RafachoD B Zoccal
Oct 8, 2019·High Altitude Medicine & Biology·Tetiana V SerebrovskaValeriy B Shatylo
Feb 27, 2020·Medicine and Science in Sports and Exercise·Samarmar ChacarounSamuel Verges
Jul 2, 2020·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Samarmar ChacarounSamuel Verges

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.